Development of monoclonal antibodies and ELISA specific for the mouse vascular endocan

Journal of Immunological Methods

Volumn 378, Issue 1-2, 2012, Pages 88-94

  Depontieu, Florence ^a,b,c   Caires, Nathalie de Freitas ^a,b,c,f   Gourcerol, Delphine ^a,b,c,d   Giordano, Julie ^a,b,c,d   Grigoriu, Bogdan ^a,b,e   Delehedde, Maryse ^a,b,c,f   Lassalle, Philippe ^a,b,c  

^a INSERM U1019   (France)

^b INSTITUT PASTEUR DE LILLE   (France)

^c UNIV LILLE   (France)

^d LILLE UNIVERSITY HOSPITAL   (France)

^e GRIGORE T POPA UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

^f Lunginnov   (France)

Author keywords

Biomarker; ELISA; Monoclonal antibodies; Mouse endocan; Tumor

Indexed keywords

MESSENGER RNA; MONOCLONAL ANTIBODY; PROTEOGLYCAN; UNCLASSIFIED DRUG; VASCULAR ENDOCAN;

ANTIBODY PRODUCTION; ARTICLE; CARCINOGENESIS; EMBRYO; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; LIVER CELL CARCINOMA; LUNG CANCER; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SERUM; TUMOR VASCULARIZATION;

ANIMALS; ANTIBODIES, MONOCLONAL; CELL LINE; CHO CELLS; CRICETINAE; ENZYME-LINKED IMMUNOSORBENT ASSAY; HEK293 CELLS; HT29 CELLS; HUMANS; MICE; MICE, 129 STRAIN; MICE, INBRED C57BL; MICE, SCID; NEOPLASM PROTEINS; NEOPLASMS; PROTEOGLYCANS; RATS;

MUS; RATTUS;

EID: 84859433307     PISSN: 00221759     EISSN: 18727905     Source Type: Journal    
DOI: 10.1016/j.jim.2012.02.009     Document Type: Article

References (27)

1. Abid M.R., Yi X., Yano K., Shih S.C., Aird W.C. Vascular endocan is preferentially expressed in tumor endothelium. Microvasc. Res. 2006, 72:136.
2. Aitkenhead M., Wang S.J., Nakatsu M.N., Mestas J., Heard C., Hughes C.C. Identification of endothelial cell genes expressed in an in vitro model of angiogenesis: induction of ESM-1, (beta)ig-h3, and NrCAM. Microvasc. Res. 2002, 63:159.
3. Amatschek S., Koenig U., Auer H., Steinlein P., Pacher M., Gruenfelder A., Dekan G., Vogl S., Kubista E., Heider K.H., Stratowa C., Schreiber M., Sommergruber W. Tissue-wide expression profiling using cDNA subtraction and microarrays to identify tumor-specific genes. Cancer Res. 2004, 64:844.
4. Auguste P., Lemiere S., Larrieu-Lahargue F., Bikfalvi A. Molecular mechanisms of tumor vascularization. Crit. Rev. Oncol. Hematol. 2005, 54:53.
5. Bechard D., Gentina T., Delehedde M., Scherpereel A., Lyon M., Aumercier M., Vazeux R., Richet C., Degand P., Jude B., Janin A., Fernig D.G., Tonnel A.B., Lassalle P. Endocan is a novel chondroitin sulfate/dermatan sulfate proteoglycan that promotes hepatocyte growth factor/scatter factor mitogenic activity. J. Biol. Chem. 2001, 276:48341.
6. Bechard D., Meignin V., Scherpereel A., Oudin S., Kervoaze G., Bertheau P., Janin A., Tonnel A., Lassalle P. Characterization of the secreted form of endothelial-cell-specific molecule 1 by specific monoclonal antibodies. J. Vasc. Res. 2000, 37:417.
7. Borczuk A.C., Shah L., Pearson G.D., Walter K.L., Wang L., Austin J.H., Friedman R.A., Powell C.A. Molecular signatures in biopsy specimens of lung cancer. Am. J. Respir. Crit. Care Med. 2004, 170:167.
8. Carson-Walter E.B., Watkins D.N., Nanda A., Vogelstein B., Kinzler K.W., St Croix B. Cell surface tumor endothelial markers are conserved in mice and humans. Cancer Res. 2001, 61:6649.
9. Cifola I., Spinelli R., Beltrame L., Peano C., Fasoli E., Ferrero S., Bosari S., Signorini S., Rocco F., Perego R., Proserpio V., Raimondo F., Mocarelli P., Battaglia C. Genome-wide screening of copy number alterations and LOH events in renal cell carcinomas and integration with gene expression profile. Mol. Cancer 2008, 7:6.
10. Depontieu F., Grigoriu B.D., Scherpereel A., Adam E., Delehedde M., Gosset P., Lassalle P. Loss of endocan tumorigenic properties after alternative splicing of exon 2. BMC Cancer 2008, 8:14.
11. Feinberg M. Guide de validation des méthodes d'analyse, in "Labo-Stat". "Labo-Stat", Editions TEC&DOC, Lavoisier 2009.
12. Grigoriu B.D., Depontieu F., Scherpereel A., Gourcerol D., Devos P., Ouatas T., Lafitte J.J., Copin M.C., Tonnel A.B., Lassalle P. Endocan expression and relationship with survival in human non-small cell lung cancer. Clin. Cancer Res. 2006, 12:4575.
13. Huang G.W., Tao Y.M., Ding X. Endocan expression correlated with poor survival in human hepatocellular carcinoma. Dig. Dis. Sci. 2008, 54:389.
14. Lacroix L., Lazar V., Michiels S., Ripoche H., Dessen P., Talbot M., Caillou B., Levillain J.P., Schlumberger M., Bidart J.M. Follicular thyroid tumors with the PAX8-PPARgamma1 rearrangement display characteristic genetic alterations. Am. J. Pathol. 2005, 167:223.
15. Leroy X., Aubert S., Zini L., Franquet H., Kervoaze G., Villers A., Delehedde M., Copin M.C., Lassalle P. Vascular endocan (ESM-1) is markedly overexpressed in clear cell renal cell carcinoma. Histopathology 2010, 56:180.
16. Maurage C.A., Adam E., Mineo J.F., Sarrazin S., Debunne M., Siminski R.M., Baroncini M., Lassalle P., Blond S., Delehedde M. Endocan expression and localization in human glioblastomas. J. Neuropathol. Exp. Neurol. 2009, 68:633.
17. Nanda A., Buckhaults P., Seaman S., Agrawal N., Boutin P., Shankara S., Nacht M., Teicher B., Stampfl J., Singh S., Vogelstein B., Kinzler K.W., St Croix B. Identification of a binding partner for the endothelial cell surface proteins TEM7 and TEM7R. Cancer Res. 2004, 64:8507.
18. Nanda A., Karim B., Peng Z., Liu G., Qiu W., Gan C., Vogelstein B., St Croix B., Kinzler K.W., Huso D.L. Tumor endothelial marker 1 (Tem1) functions in the growth and progression of abdominal tumors. Proc. Natl. Acad. Sci. U. S. A. 2006, 103:3351.
19. Ruoslahti E. Specialization of tumour vasculature. Nat. Rev. Cancer 2002, 2:83.
20. Scherpereel A., Depontieu F., Grigoriu B., Cavestri B., Tsicopoulos A., Gentina T., Jourdain M., Pugin J., Tonnel A.B., Lassalle P. Endocan, a new endothelial marker in human sepsis. Crit. Care Med. 2006, 34:532.
21. Scherpereel A., Gentina T., Grigoriu B., Senechal S., Janin A., Tsicopoulos A., Plenat F., Bechard D., Tonnel A.B., Lassalle P. Overexpression of endocan induces tumor formation. Cancer Res. 2003, 63:6084.
22. Seftor E.A., Meltzer P.S., Schatteman G.C., Gruman L.M., Hess A.R., Kirschmann D.A., Seftor R.E., Hendrix M.J. Expression of multiple molecular phenotypes by aggressive melanoma tumor cells: role in vasculogenic mimicry. Crit. Rev. Oncol. Hematol. 2002, 44:17.
23. St Croix B., Rago C., Velculescu V., Traverso G., Romans K.E., Montgomery E., Lal A., Riggins G.J., Lengauer C., Vogelstein B., Kinzler K.W. Genes expressed in human tumor endothelium. Science 2000, 289:1197.
24. Tsai J.C., Zhang J., Minami T., Voland C., Zhao S., Yi X., Lassalle P., Oettgen P., Aird W.C. Cloning and characterization of the human lung endothelial-cell-specific molecule-1 promoter. J. Vasc. Res. 2002, 39:148.
25. van 't Veer L.J., Dai H., van de Vijver M.J., He Y.D., Hart A.A., Mao M., Peterse H.L., van der Kooy K., Marton M.J., Witteveen A.T., Schreiber G.J., Kerkhoven R.M., Roberts C., Linsley P.S., Bernards R., Friend S.H. Gene expression profiling predicts clinical outcome of breast cancer. Nature 2002, 415:530.
26. Wang X., Brownstein M.J., Young W.S. PG25, a pineal-specific cDNA, cloned by differential display PCR (DDPCR) and rapid amplification of cDNA ends (RACE). J. Neurosci. Methods 1997, 73:187.
27. Weinschenk T., Gouttefangeas C., Schirle M., Obermayr F., Walter S., Schoor O., Kurek R., Loeser W., Bichler K.H., Wernet D., Stevanovic S., Rammensee H.G. Integrated functional genomics approach for the design of patient-individual antitumor vaccines. Cancer Res. 2002, 62:5818.